SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003194
Filing Date
2018-04-26
Accepted
2018-04-26 07:03:27
Documents
5
Period of Report
2018-06-14
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235307zdef14a.htm DEF 14A 362471
2 G1000811.JPG g1000811.jpg GRAPHIC 10782
3 G619118.JPG g619118.jpg GRAPHIC 5740
4 G92082BAI001.GIF g92082bai001.gif GRAPHIC 111353
5 G92082BAI002.GIF g92082bai002.gif GRAPHIC 89496
  Complete submission text file 0001047469-18-003194.txt   663446
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37813 | Film No.: 18776098
SIC: 2834 Pharmaceutical Preparations